Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT05996159

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05996159
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05996159. Randomized; no masking; primary purpose treatment. Start 2023-11-07 (actual); primary completion 2026-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation
Condition
Paroxysmal Atrial Fibrillation
Intervention (Device)
QDOT MicroTM catheter
Intervention (Device)
AI-guided ablation only for PVI
Lead sponsor
Seoul National University Hospital (class: other)

Record details

Record id
cardio:ct-nct05996159
Content hash
17bc7e051b4b77e0cca0ff9d216e6fc390810f1a5c95947ce58998d00a11f062